Evaluation of efficacy and recurrence for anti-vascular endothelial growth factor therapy in idiopathic choroidal neovascularization

Table 4 Univariate analysis of morphological improvement

Characteristics	OR	95%CI	P
Number of injections(times)	0.629	0.253–1.566	0.319
Baseline BCVA(letters)	1.063	1.004–1.126	0.036^*
Age(years)	0.973	0.904–1.048	0.473
Baseline CRT(μm)	0.999	0.992–1.006	0.788
Duration of disease(weeks)	0.980	0.931–1.032	0.444

ISSN: 1471-2415